Nuance Pharma Partners with Stallergenes Greer to Launch Actair in China
Nuance Pharma, an innovation-focused biopharmaceutical company, and Stallergenes Greer, a global leader in the allergy...
Nuance Pharma
Nuance Pharma’s Ohtuvayre Meets Primary Endpoints in COPD Study
China-based Nuance Pharma announced positive topline results from the ENHANCE-CHINA study (NCT05743075) for its nebulized...
Nuance Pharma’s Ohtuvayre Receives Regulatory Approval in Macau for COPD Treatment
China-based Nuance Pharma announced that it has received regulatory approval in Macau for its Ohtuvayre...
Nuance Pharma Completes Enrollment for Phase III COPD Trial of Ohtuvayre in China
Nuance Pharma, a China-based pharmaceutical company, has announced the completion of patient enrollment for the...
Nuance Pharma Wins Arbitration, Rescinds Licensing Deal with Antibe Therapeutics
Nuance Pharma, a China-based pharmaceutical company, has received a favorable arbitration verdict from a Singapore...
Nuance Pharma Partners with DKSH to Launch Bentrio Nasal Spray in Hong Kong and Macau
China-based Nuance Pharma has announced a partnership with DKSH Hong Kong Business Unit Healthcare to...
Nuance Pharma Gets NMPA Green Light for Ensifentrine COPD Trials in China
China-based Nuance Pharma has secured approval from the National Medical Products Administration (NMPA) to conduct...
Nuance Pharma Initiates Phase I Study for Ketorolac IV Infusion (NTM-001)
China-based Nuance Pharma announced the initiation of subject enrollment and the first drug infusion in...